Lifestyle and polybrominated diphenyl ethers in human milk in the United States: A pilot study

Polybrominated diphenyl ethers (PBDE) are a class of brominated flame retardants with some congeners having the ability to accumulate in body lipids. The incorporation of PBDE in consumer products found primarily in the indoor environment suggests that routes of exposure include inhalation of indoor air and contact with indoor dust. The purpose of this study was to test the hypothesis that lifestyle factors, and in particular the proximity and use of products likely to contain PBDE in the indoor environment, are primarily responsible for levels of PBDE found in human milk. Human milk samples were taken from two populations of lactating women in the same geographic region of the United States: one “typical” of US suburban lifestyle, and the other practicing a traditional Amish lifestyle, which excludes many modern amenities containing PBDE, such as computers and televisions. For a subset of the cohort, persistent organic pesticides and polychlorinated biphenyls (PCB) were also measured in human milk samples. Despite the small number of participants, there is evidence suggestive of Amish women having lower PBDE concentrations in their milk. In addition, the nonsignificant differences in levels of PCBs and pesticides between the two groups of women as compared to the significant differences in levels of PBDE suggest an important route of exposure for PBDE other than diet. Information prepared for study participants is provided to initiate a dialogue on how to best communicate biomonitoring findings to study participants and to the public in general.     

Assigning concentration values for dioxin and furan congeners in human serum when measurements are below limits of detection: an observational approach

Concentrations of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) in dietary sources for humans have been declining over the previous two decades. These declines have been accompanied by decreases in concentrations of these compounds in humans, as evidenced by measurements in blood and milk. Because of the decreasing concentrations of PCDD/PCDFs in the environment and in humans, measuring PCDD/PCDF congeners in humans has become increasingly difficult, despite advances in analytic methods. An observational approach was recently described to address the quandary of non-detectable results in determining toxic equivalents. This approach, called the congener ratio approach, is specifically for cases where concentrations of 2,3,7,8-TCDD (TCDD) are below the limit of detection (LOD), and where concentrations of 1,2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD) are equal to or above the LOD. Development of this approach relied on evaluating data on measured concentrations of TCDD and PeCDD in human serum from the general population. The congener ratio approach for TCDD and PeCDD was based on the concentration of TCDD being approximately 40% that of PeCDD in serum from the general population. Additional analyses presented here reveal that when concentrations of both congeners are above the LOD, the data appear to generally support the congener ratio approach for TCDD and PeCDD, with the caveat that gender may affect the ratio. However, the TCDD/PeCDD relation is less clear when TCDD is less than the LOD; in this situation, the relation overpredicts levels of TCDD approximately 80% of the time for the 2001-2002 NHANES database. Using the congener ratio approach for other PCDD/PCDF congeners requires assessing the correlation and the frequency of detection for both TCDD and PeCDD.